Dataset
Febuxostat; LC-ESI-QFT; MS2; CE: 150%; R=15000; [M+H]+
Chemical Information
| InChI | InChI=1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20) |
|---|---|
| SMILES | CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O |
| InChI Key | BQSJTQLCZDPROO-UHFFFAOYSA-N |
| Molecular Formula | C16H16N2O3S |
| Exact Mass | 316.088 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by-sa/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Eawag-EQ01100208 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2024-06-14 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| 134018 | PubChem |
| PD009360 | ProbesDrugs |
| 14899120 | PubChem: Thomson Pharma |
| 144060-53-7 | ACToR |
| Febuxostat(Uloric) | Selleck |
| LSM-3064 | LINCS |
| 6719182 | eMolecules |
| SCHEMBL249339 | SureChEMBL |
| MCULE-6974079178 | Mcule |
| CB4841564 | ChemicalBook |
| 92458 | Brenda |
| febuxostat | DailyMed |
| CHEMBL1164729 | ChEMBL |
| TEI | PDBe |
| 12014717 | PubChem: Drugs of the Future |
| 6817 | Guide to Pharmacology |
| ZINC000000005423 | ZINC |
| 1137 | DrugCentral |
| 31596 | ChEBI |
| DTXSID8048650 | EPA CompTox Dashboard |
| 50320491 | BindingDB |
| DB04854 | DrugBank |
| HMDB0252185 | Human Metabolome Database |
| FEBUXOSTAT | DailyMed |
| HIQQAB | CCDC |
| FEBUXOSTAT | rxnorm |
| ULORIC | rxnorm |
| TMX-67 | clinicaltrials |
| ULORIC | clinicaltrials |
| FEBUXOSTAT | clinicaltrials |
| ADENURIC | clinicaltrials |
| HY-14268 | MedChemExpress |
| J551.973J | Nikkaji |
| 101V0R1N2E | FDA SRS |
| CB22508843 | ChemicalBook |
| The data in this table is sourced from UniChem at EBI. | |